Benzinga | Jun 14, 2021 09:16AM EDT

ClearPoint Neuro Set To Join Russell 3000 Index June 28

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is set to join the broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.



The annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 7, ranking them by total market capitalization. ClearPoint Neuro's membership in the US all-cap Russell 3000(r) Index, which remains in place for one year, will result in automatic inclusion in the small-cap Russell 2000 Index as well as the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings, and style attributes.

"We are pleased to be included in the Russell 3000," stated Danilo D'Alessandro, CFO of ClearPoint Neuro. "This should further our strategy of continuing to build our institutional shareholder base."

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $10.6 trillion in assets are benchmarked against Russell's US indexes. Russell indexes are part of FTSE Russell, a leading global index provider.

For more information on the Russell 3000(r) Index and the Russell indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website.